Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JD Health InternationalJDHIF 91 Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus rates JDHIF with a GF Score™ of 91/100 and a GF Value™ of $7.67. The stock has 1 warning sign investors should review. Among 683 Healthcare Providers & Services companies, JD Health International ranks better than 88.43% on this metric.
JD Health International's Enterprise Value for the quarter that ended in Jun. 2026 was $11,790 Mil.
JD Health International's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $1,079 Mil. JD Health International's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 0.00%.
The historical rank and industry rank for JD Health International's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
JDHIF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -25.09 Med: 1.13 Max: 17.4
Current: 11.74
During the past 9 years, the highest Earnings Yield (Joel Greenblatt) of JD Health International was 17.40%. The lowest was -25.09%. And the median was 1.13%.
JDHIF's Earnings Yield (Joel Greenblatt) % is ranked better than 88.43% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 3.7
vs JDHIF: 11.74
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. JD Health International's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
JD Health International (OTCPK:JDHIF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
JD Health International Earnings Yield (Joel Greenblatt) % Related Terms
JD Health International Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for JD Health International's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Earnings Yield (Joel Greenblatt) % Chart
JD Health International Earnings Yield (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where JD Health International's Earnings Yield (Joel Greenblatt) % falls into.
JD Health International Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
JD Health Internationals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 0.00% mean?
JD Health International (JDHIF) has a Earnings Yield (Joel Greenblatt) % of 0.00% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on JD Health International and its competitors. According to the industry distribution chart, JD Health International ranks #79 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 11.6%.
Is JD Health International's Earnings Yield (Joel Greenblatt) % too high?
JD Health International's current Earnings Yield (Joel Greenblatt) % is 0.00%. Based on the distribution chart, JD Health International ranks #79 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JD Health International has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Earnings Yield (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #79 out of 683 companies for Earnings Yield (Joel Greenblatt) %. This places JD Health International in the top 12% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 3.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.70, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Earnings Yield (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current Earnings Yield (Joel Greenblatt) % of 0.00%. The stock's GF Value™ is $7.67, compared to a current price of $5.85 — trading 23.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 0.00%. JD Health International's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For JD Health International (JDHIF), the current Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 23.7% below its estimated GF Value™ of $7.67.
Key valuation signals for JDHIF:
Earnings Yield (Joel Greenblatt) %: 0.00%
GF Value™: $7.67 vs. price of $5.85 (23.7% below fair value)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
91GF Score
Get the complete analysis for JDHIF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
